Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Generation Bio Co. - Common stock (NQ: GBIO )

0.6800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Generation Bio Co. - Common stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
From Generation Bio Co.
Via GlobeNewswire
Where Generation Bio Stands With Analysts
Via Benzinga
The Latest Analyst Ratings for Generation Bio
Via Benzinga
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Generation Bio Co.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Generation Bio
Via Benzinga
Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines
Via Benzinga
Generation Bio Reports Second Quarter 2023 Financial Results
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025 
From Generation Bio Co.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
From Generation Bio Co.
Via GlobeNewswire
Generation Bio to Present at the JMP Securities Life Sciences Conference
From Generation Bio Co.
Via GlobeNewswire
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In Q1 2023 – Tesla, Apple, AMC, DWAC And More
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Generation Bio Co.
Via GlobeNewswire
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In March – Including Tesla, Apple, AMC And More
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
From Generation Bio Co.
Via GlobeNewswire
Why Generation Bio Shares Are Trading Higher Today
Generation Bio (NASDAQ: GBIO) shares are trading higher on Thursday after the company and Moderna (NASDAQ: MRNA) announced a collaboration to develop non-viral genetic medicines. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Generation Bio Co. (NASDAQ: GBIO) Leading the Way in Thursday Trading Based on Percentage Gain
Via Investor Brand Network
Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today's Top Stories
Bloomberg 
Via Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
From Generation Bio Co.; Moderna
Via GlobeNewswire
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
From Generation Bio Co.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.